Traws Pharma, Inc.

Nasdaq TRAW · Newtown, PA

Works in Hematology · Infectious disease · Oncology · Respiratory

Traws Pharma, Inc. is a clinical trial sponsor based in Newtown, PA, listed as Nasdaq TRAW. It has 3 active clinical trials with 302 planned participants, in Hematology, Infectious disease, Oncology and Respiratory. Since 2021 it has completed 5 trials and stopped 2 early.

Trial track record · since 2021

3Active trials302 planned participants
5Completed0 with results posted
2Stopped early29% of finished trials

Financials · Nasdaq TRAW

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Fundraising

Pipeline · 3 active trials

StageTrialStatus

Questions about Traws Pharma, Inc

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-11-06.

Approve Suite is not affiliated with Traws Pharma, Inc..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.